Urinary tract infections are the most common outpatient infections, but predicting the
probability of urinary tract infections through symptoms and test results can be complex. The …

The necessity for the discovery of innovative antimicrobials to treat life-threatening diseases
has increased as multidrug-resistant bacteria has spread. Due to antibiotics' availability over …

Rising rates of resistance to antimicrobial drugs among Enterobacteriaceae limit the choice
of reliably active forms of these drugs. We evaluated the evidence on fosfomycin as a …

Since 2000, Escherichia coli producing CTX-M enzymes (especially CTX-M-15) have
emerged worldwide as important causes of community-onset urinary tract infections (UTIs) …

Background Extended-spectrum β-lactamase (ESBL)-producingEscherichia coliis an
increasingly important group of community pathogens worldwide. These organisms are …

Bacteria are the leading cause of infections after solid organ transplantation. In recent years,
a progressive growth in the incidence of multidrug‐resistant (MDR) and extensively‐drug …

The progressive increase of extended‐spectrum β‐lactamase (ESBL)‐producing enteric
bacteria in recent years has called for a re‐evaluation of current antibiotic therapy for these …

Developing novel antimicrobial agents has become a necessitate due to the increasing rate
of microbial resistance to antibiotics. All the newly adamantane derivatives were evaluated …

Urinary tract infections (UTI) are one of the most common indications for antibiotic
prescriptions in the outpatient setting. Given rising rates of antibiotic resistance among …

Piperacillin–tazobactam is a β-lactam/β-lactamase inhibitor combination with a broad
spectrum of antibacterial activity that includes Gram-positive and-negative aerobic and …